ENTITY
Dexcom Inc

Dexcom Inc (DXCM US)

51
Analysis
Health CareUnited States
DexCom Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The Company has developed a small implantable device that continuously measures glucose levels in subcutaneous tissue just under the skin, and a small external receiver to which the sensor transmits glucose levels at specified intervals.
more
06 Oct 2021 11:10

MicroTech (微泰医疗) IPO: Demanding Valuation Despite a Decent Story

We provided an update for the book building of MicroTech Medical which sells diabetes management products including patch insulin pump (Equil) and...

Logo
344 Views
Share
05 Oct 2021 09:53

MicroTech (微泰医疗) Pre-IPO: Thoughts on Valuation

In this note, we provide a financial forecast for the MicroTech's main products (Equil, BGMS, CGMS) and our thoughts on the pre-money valuation.

Logo
396 Views
Share
bearishTesla
02 Aug 2020 11:24

Tesla: S&P500 Inclusion Secured?

On 22 July, Tesla Motors (TSLA US) reported a profit for Q2 2020 making it the fourth consecutive quarterly profit. Hitting that milestone makes...

Logo
750 Views
Share
bearishS&P 500 INDEX
22 Apr 2020 08:38

U.S. Equity Strategy: Several Indicators Suggest a Pullback Likely

Despite the bulls still being in control, we have several ongoing concerns and we cannot rule out the potential for a pullback. Below we highlight...

Logo
545 Views
Share
09 Feb 2017 09:14

Trump Health Effect: What Is Next for the Consumer Health Industry Under Trump's Leadership?

While the US consumer health industry will remain a strong centre for investment, development and technology innovation in 2017 and is expected to...

x